27/06/2024
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Jul »
27/06/2024
Jun 27, 2024, 10:13 |
Insight
ESMO deep dive on breast cancer
The European Society for Medical Oncology (ESMO) shared on LinkedIn: “Make the most of your…
Jun 27, 2024, 10:05 |
Blog
CancerLinQ - TraiLinQ is revolutionizing the use of data to fill clinical trials
CancerLinQ shared on X: "Day 2 of the 2024 Association of American Cancer Institutes meeting is…
Jun 27, 2024, 09:54 |
Blog
About the challenges that survivors face - Childhood Cancer International - Europe
Childhood Cancer International - Europe shared a post on LinkedIn: “International Childhood Cancer Survivors Week…
Jun 27, 2024, 09:29 |
Blog
The LBAs for the ESMOGI24 are now live
ESMO shared on X: "The LBAs for the ESMO Gastrointestinal Cancers Congress 2024 are now live.…
Jun 27, 2024, 09:10 |
Insight
The promise of immuno-oncology in the neoadjuvant setting - ESMO
The European Society for Medical Oncology (ESMO) shared on LinkedIn: “The promise of immuno-oncology in…
Jun 27, 2024, 09:01 |
Insight
Piotr Wysocki: Anti-inflammatory drugs improve outcomes of patients with early PIK3CA-mutated colorectal cancer
Piotr Wysocki recently posted on LinkedIn: "For many years, anti-inflammatory drugs, mainly aspirin and celecoxib, have…
Jun 27, 2024, 08:56 |
Societies
Teresa Macarulla kicks it off at ESMOGI24
Lizzy Smyth, Consultant Medical Oncologist in upper GI oncology at Oxford University, shared on X:…
Jun 27, 2024, 08:45 |
Blog
Some papers to read today suggested by Wafik S. El-Deiry
Wafik S. El-Deiry, Associate Dean for Oncologic Sciences at the Warren Alpert Medical School, shared…
Jun 27, 2024, 08:37 |
Societies
Angela Lamarca: Subgroup analysis on NETTER2
Angela Lamarca, HPB and NET Medical Oncologist at Jimenez Diaz Foundation, shared a post on X:…
Jun 27, 2024, 08:31 |
Societies
Arndt Vogel: Phase I study of the PKMYT1 inhibitor lunresertib in combination with FOLFIRI
Arndt Vogel shared on X: "Phase I study of the PKMYT1 inhibitor lunresertib in combination…
5
6
7
8
9
All:
98
Posts:
61 - 70
OncoDaily at ASCO 2024: OncoDaily Party, Yvonne Award and much more
Tedros Adhanom Ghebreyesus received University of Nicosia’s Honorary Doctorate
Lisa A. Lacasse: A major milestone towards Congress passing the bipartisan MCED Act
July is Sarcoma Awareness Month
25 Posts You Should Not Miss From ESMOGI24!
Facebook
RSS Feed
Twitter
Linkedin
Youtube